Search results for: 'generic drug market'

Multimodal sensor fusion is an advanced perception technology that combines data from multiple sensors, including cameras, LiDAR, radar, ultrasonic sensors, thermal cameras, and inertial measurement units (IMUs), to give robots and autonomous systems a more accurate, reliable, and comprehensive understanding of their environment. It overcomes the l...

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis ...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical...

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

The research provides an analysis of the North American combined heat and power (CHP) market. It presents a forecast of the CHP market and lists the challenges and opportunities along with the regulatory framework and policies. The study also covers the current state and future potential of CHP in North America. Apart from the technological advance...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these ...